Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugsdesigned as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells.
The research report studies the Antibody-drug Conjugate market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Global Antibody-drug Conjugate market: Drivers and Restraints
This section covers the various factors driving the global Antibody-drug Conjugate market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by revenue and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.
Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.
Global Antibody-drug Conjugate market: Segment Analysis
The global Antibody-drug Conjugate market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue and sales for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided sales according to the consumption of the product.
Global Antibody-drug Conjugate market: Regional Analysis
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
Global Antibody-drug Conjugate market: Key Players
The report lists the major manufacturers in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
By the product type, the market is primarily split into
Adcetris
Kadcyla
By the end users/application, this report covers the following segments
Breast Cancer
Lymphoma
Competitive Landscape:
The report provides a list of all the key players in the Antibody-drug Conjugate market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.
The Antibody-drug Conjugate key manufacturers in this market include:
Agensys
Concortis Biotherapeutics
Sanofi
Celldex Therapeutics
Synthon Holding BV
The research report studies the Antibody-drug Conjugate market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Global Antibody-drug Conjugate market: Drivers and Restraints
This section covers the various factors driving the global Antibody-drug Conjugate market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by revenue and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.
Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.
Global Antibody-drug Conjugate market: Segment Analysis
The global Antibody-drug Conjugate market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue and sales for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided sales according to the consumption of the product.
Global Antibody-drug Conjugate market: Regional Analysis
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
Global Antibody-drug Conjugate market: Key Players
The report lists the major manufacturers in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
By the product type, the market is primarily split into
Adcetris
Kadcyla
By the end users/application, this report covers the following segments
Breast Cancer
Lymphoma
Competitive Landscape:
The report provides a list of all the key players in the Antibody-drug Conjugate market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.
The Antibody-drug Conjugate key manufacturers in this market include:
Agensys
Concortis Biotherapeutics
Sanofi
Celldex Therapeutics
Synthon Holding BV
Table of Contents
1 Antibody-drug Conjugate Market Overview
1.1 Antibody-drug Conjugate Product Overview
1.2 Antibody-drug Conjugate Market Segment by Type
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Global Antibody-drug Conjugate Market Size by Type (2015-2026)
1.3.1 Global Antibody-drug Conjugate Market Size Overview by Type (2015-2026)
1.3.2 Global Antibody-drug Conjugate Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Antibody-drug Conjugate Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Antibody-drug Conjugate Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Antibody-drug Conjugate Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Antibody-drug Conjugate Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Antibody-drug Conjugate Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Antibody-drug Conjugate Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Antibody-drug Conjugate Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.2 Europe Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
2 Global Antibody-drug Conjugate Market Competition by Company
2.1 Global Top Players by Antibody-drug Conjugate Sales (2015-2020)
2.2 Global Top Players by Antibody-drug Conjugate Revenue (2015-2020)
2.3 Global Top Players Antibody-drug Conjugate Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Antibody-drug Conjugate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody-drug Conjugate Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugate Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody-drug Conjugate Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019)
2.7 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
2.8 Key Manufacturers Antibody-drug Conjugate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Antibody-drug Conjugate Status and Outlook by Region (2015-2026)
3.1 Global Antibody-drug Conjugate Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Antibody-drug Conjugate Market Size Market Share by Region (2015-2020)
3.2.1 Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
3.2.2 Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
3.2.3 Global Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Antibody-drug Conjugate Market Size Market Share by Region (2021-2026)
3.3.1 Global Antibody-drug Conjugate Sales Market Share by Region (2021-2026)
3.3.2 Global Antibody-drug Conjugate Revenue Market Share by Region (2021-2026)
3.3.3 Global Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.4.1 North America Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.4.2 North America Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.6 Europe Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.6.1 Europe Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.6.2 Europe Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.7 Latin America Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.7.1 Latin America Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.7.2 Latin America Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Antibody-drug Conjugate Sales YoY Growth (2015-2026)
4 Global Antibody-drug Conjugate by Application
4.1 Antibody-drug Conjugate Segment by Application
4.1.1 Breast Cancer
4.1.2 Lymphoma
4.2 Global Antibody-drug Conjugate Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Antibody-drug Conjugate Historic Sales by Application (2015-2020)
4.4 Global Antibody-drug Conjugate Forecasted Sales by Application (2021-2026)
4.5 Key Regions Antibody-drug Conjugate Market Size by Application
4.5.1 North America Antibody-drug Conjugate by Application
4.5.2 Europe Antibody-drug Conjugate by Application
4.5.3 Asia-Pacific Antibody-drug Conjugate by Application
4.5.4 Latin America Antibody-drug Conjugate by Application
4.5.5 Middle East and Africa Antibody-drug Conjugate by Application
5 North America Antibody-drug Conjugate Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
5.1.2 North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
5.2.2 North America Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
5.3.2 Canada Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6 Europe Antibody-drug Conjugate Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
6.1.2 Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
6.2.2 Europe Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.2 France Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.3 U.K. Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.4 Italy Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.5 Russia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7 Asia-Pacific Antibody-drug Conjugate Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.2 Japan Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.3 South Korea Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.4 India Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.5 Australia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.8 Thailand Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.10 Philippines Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
8 Latin America Antibody-drug Conjugate Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
8.1.2 Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
8.2.2 Latin America Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
8.3.2 Brazil Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
8.3.3 Argentina Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
9 Middle East and Africa Antibody-drug Conjugate Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
10 Company Profiles and Key Figures in Antibody-drug Conjugate Business
10.1 Agensys
10.1.1 Agensys Corporation Information
10.1.2 Agensys Description, Business Overview and Total Revenue
10.1.3 Agensys Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Agensys Antibody-drug Conjugate Products Offered
10.1.5 Agensys Recent Development
10.2 Concortis Biotherapeutics
10.2.1 Concortis Biotherapeutics Corporation Information
10.2.2 Concortis Biotherapeutics Description, Business Overview and Total Revenue
10.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.2.5 Concortis Biotherapeutics Recent Development
10.3 Sanofi
10.3.1 Sanofi Corporation Information
10.3.2 Sanofi Description, Business Overview and Total Revenue
10.3.3 Sanofi Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Sanofi Antibody-drug Conjugate Products Offered
10.3.5 Sanofi Recent Development
10.4 Celldex Therapeutics
10.4.1 Celldex Therapeutics Corporation Information
10.4.2 Celldex Therapeutics Description, Business Overview and Total Revenue
10.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Celldex Therapeutics Antibody-drug Conjugate Products Offered
10.4.5 Celldex Therapeutics Recent Development
10.5 Synthon Holding BV
10.5.1 Synthon Holding BV Corporation Information
10.5.2 Synthon Holding BV Description, Business Overview and Total Revenue
10.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Synthon Holding BV Antibody-drug Conjugate Products Offered
10.5.5 Synthon Holding BV Recent Development
...
11 Antibody-drug Conjugate Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody-drug Conjugate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody-drug Conjugate Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Market Opportunities and Drivers
11.4.2 Market Challenges
11.4.3 Market Risks
11.4.4 Porter’s Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
1 Antibody-drug Conjugate Market Overview
1.1 Antibody-drug Conjugate Product Overview
1.2 Antibody-drug Conjugate Market Segment by Type
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Global Antibody-drug Conjugate Market Size by Type (2015-2026)
1.3.1 Global Antibody-drug Conjugate Market Size Overview by Type (2015-2026)
1.3.2 Global Antibody-drug Conjugate Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Antibody-drug Conjugate Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Antibody-drug Conjugate Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Antibody-drug Conjugate Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Antibody-drug Conjugate Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Antibody-drug Conjugate Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Antibody-drug Conjugate Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Antibody-drug Conjugate Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.2 Europe Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Antibody-drug Conjugate Sales Breakdown by Type (2015-2026)
2 Global Antibody-drug Conjugate Market Competition by Company
2.1 Global Top Players by Antibody-drug Conjugate Sales (2015-2020)
2.2 Global Top Players by Antibody-drug Conjugate Revenue (2015-2020)
2.3 Global Top Players Antibody-drug Conjugate Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Antibody-drug Conjugate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody-drug Conjugate Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugate Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody-drug Conjugate Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019)
2.7 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
2.8 Key Manufacturers Antibody-drug Conjugate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Antibody-drug Conjugate Status and Outlook by Region (2015-2026)
3.1 Global Antibody-drug Conjugate Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Antibody-drug Conjugate Market Size Market Share by Region (2015-2020)
3.2.1 Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
3.2.2 Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
3.2.3 Global Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Antibody-drug Conjugate Market Size Market Share by Region (2021-2026)
3.3.1 Global Antibody-drug Conjugate Sales Market Share by Region (2021-2026)
3.3.2 Global Antibody-drug Conjugate Revenue Market Share by Region (2021-2026)
3.3.3 Global Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.4.1 North America Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.4.2 North America Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.6 Europe Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.6.1 Europe Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.6.2 Europe Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.7 Latin America Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.7.1 Latin America Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.7.2 Latin America Antibody-drug Conjugate Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Antibody-drug Conjugate Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Antibody-drug Conjugate Sales YoY Growth (2015-2026)
4 Global Antibody-drug Conjugate by Application
4.1 Antibody-drug Conjugate Segment by Application
4.1.1 Breast Cancer
4.1.2 Lymphoma
4.2 Global Antibody-drug Conjugate Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Antibody-drug Conjugate Historic Sales by Application (2015-2020)
4.4 Global Antibody-drug Conjugate Forecasted Sales by Application (2021-2026)
4.5 Key Regions Antibody-drug Conjugate Market Size by Application
4.5.1 North America Antibody-drug Conjugate by Application
4.5.2 Europe Antibody-drug Conjugate by Application
4.5.3 Asia-Pacific Antibody-drug Conjugate by Application
4.5.4 Latin America Antibody-drug Conjugate by Application
4.5.5 Middle East and Africa Antibody-drug Conjugate by Application
5 North America Antibody-drug Conjugate Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
5.1.2 North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
5.2.2 North America Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
5.3.2 Canada Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6 Europe Antibody-drug Conjugate Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
6.1.2 Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
6.2.2 Europe Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.2 France Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.3 U.K. Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.4 Italy Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
6.3.5 Russia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7 Asia-Pacific Antibody-drug Conjugate Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.2 Japan Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.3 South Korea Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.4 India Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.5 Australia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.8 Thailand Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.10 Philippines Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
8 Latin America Antibody-drug Conjugate Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
8.1.2 Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
8.2.2 Latin America Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
8.3.2 Brazil Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
8.3.3 Argentina Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
9 Middle East and Africa Antibody-drug Conjugate Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Antibody-drug Conjugate Market Size YoY Growth (2015-2026)
10 Company Profiles and Key Figures in Antibody-drug Conjugate Business
10.1 Agensys
10.1.1 Agensys Corporation Information
10.1.2 Agensys Description, Business Overview and Total Revenue
10.1.3 Agensys Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Agensys Antibody-drug Conjugate Products Offered
10.1.5 Agensys Recent Development
10.2 Concortis Biotherapeutics
10.2.1 Concortis Biotherapeutics Corporation Information
10.2.2 Concortis Biotherapeutics Description, Business Overview and Total Revenue
10.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.2.5 Concortis Biotherapeutics Recent Development
10.3 Sanofi
10.3.1 Sanofi Corporation Information
10.3.2 Sanofi Description, Business Overview and Total Revenue
10.3.3 Sanofi Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Sanofi Antibody-drug Conjugate Products Offered
10.3.5 Sanofi Recent Development
10.4 Celldex Therapeutics
10.4.1 Celldex Therapeutics Corporation Information
10.4.2 Celldex Therapeutics Description, Business Overview and Total Revenue
10.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Celldex Therapeutics Antibody-drug Conjugate Products Offered
10.4.5 Celldex Therapeutics Recent Development
10.5 Synthon Holding BV
10.5.1 Synthon Holding BV Corporation Information
10.5.2 Synthon Holding BV Description, Business Overview and Total Revenue
10.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Synthon Holding BV Antibody-drug Conjugate Products Offered
10.5.5 Synthon Holding BV Recent Development
...
11 Antibody-drug Conjugate Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody-drug Conjugate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody-drug Conjugate Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Market Opportunities and Drivers
11.4.2 Market Challenges
11.4.3 Market Risks
11.4.4 Porter’s Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
